Skip to main content

and
  1. No Access

    Article

    Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis

    Recurrence of intrahepatic cholangiocarcinoma (ICC) after liver resection (LR) remains high, and optimal therapy for recurrent ICC is challenging. Herein, we assess the outcomes of patients undergoing repeat r...

    Matthew L. Holzner MD, MSc, Vincenzo Mazzaferro MD, PhD in Annals of Surgical Oncology (2024)

  2. No Access

    Article

    Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients

    Despite the increasing widespread adoption and experience in minimally invasive liver resections (MILR), open conversion occurs not uncommonly even with minor resections and as been reported to be associated w...

    Mansour Saleh MD, Franco Pascual MD, Mohammed Ghallab MD in Annals of Surgical Oncology (2024)

  3. No Access

    Article

    Unexpected Findings After Hypertrophic Techniques for Major Minimally Invasive Hepatectomies: Intraoperative Pitfalls and Management Strategies

    Cecilia Maina MD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2024)

  4. No Access

    Article

    ASO Author Reflections: Cirrhosis and Severity of Cirrhosis Negatively Affects the Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies

    Tousif Kabir MBBS, MMed, FRCSEd, Federica Cipriani MD, PhD in Annals of Surgical Oncology (2024)

  5. No Access

    Article

    Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies

    Minimally invasive liver resections (MILR) offer potential benefits such as reduced blood loss and morbidity compared with open liver resections. Several studies have suggested that the impact of cirrhosis dif...

    Federica Cipriani MD, PhD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2024)

  6. No Access

    Article

    Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study

    Although tumor size (TS) is known to affect surgical outcomes in laparoscopic liver resection (LLR), its impact on laparoscopic major hepatectomy (L-MH) is not well studied. The objectives of this study were t...

    Yutaro Kato MD, PhD, Atsushi Sugioka MD, PhD in Annals of Surgical Oncology (2023)

  7. No Access

    Article

    Risk Factors and Outcomes of Open Conversion During Minimally Invasive Major Hepatectomies: An International Multicenter Study on 3880 Procedures Comparing the Laparoscopic and Robotic Approaches

    Despite the advances in minimally invasive (MI) liver surgery, most major hepatectomies (MHs) continue to be performed by open surgery. This study aimed to evaluate the risk factors and outcomes of open conver...

    Roberto Montalti MD, PhD in Annals of Surgical Oncology (2023)

  8. No Access

    Article

    ASO Visual Abstract: Surgery for Bismuth–Corlette Type IV Perihilar Cholangiocarcinoma—Results from a Western Multicenter Collaborative Group

    Andrea Ruzzenente MD, PhD, Fabio Bagante MD, PhD in Annals of Surgical Oncology (2021)

  9. Article

    Open Access

    Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group

    Although Bismuth-Corlette (BC) type 4 perihilar cholangiocarcinoma (pCCA) is no longer considered a contraindication for curative surgery, few data are available from Western series to indicate the outcomes fo...

    Andrea Ruzzenente MD, PhD, Fabio Bagante MD, PhD in Annals of Surgical Oncology (2021)

  10. No Access

    Article

    Laparoscopic R1 Vascular Hepatectomy for Hepatocellular Carcinoma (with Video)

    Annarita Libia MD, Valentina Ferraro MD in Annals of Surgical Oncology (2021)

  11. No Access

    Article

    ASO Visual Abstract: Laparoscopic R1 Vascular Hepatectomy for Hepatocellular Carcinoma (With Video)

    Annarita Libia MD, Valentina Ferraro MD in Annals of Surgical Oncology (2021)

  12. Article

    Correction to: Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma

    In the original article Moritz Schmelzle’s last name is spelled wrong. It is correct as reflected here.

    Pim B. Olthof MD, PhD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2020)

  13. No Access

    Article

    Technical Insights on Laparoscopic Left and Right Hepatectomy for Perihilar Cholangiocarcinoma

    Francesca Ratti MD, Guido Fiorentini MD in Annals of Surgical Oncology (2020)

  14. No Access

    Article

    ASO Author Reflections: Laparoscopic Surgery of Perihilar Cholangiocarcinoma Between Oncologic Adequacy and Technical Challenges

    Francesca Ratti MD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2020)

  15. Article

    Open Access

    Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma

    Preoperative portal vein embolization (PVE) is frequently used to improve future liver remnant volume (FLRV) and to reduce the risk of liver failure after major liver resection.

    Pim B. Olthof MD, PhD, Luca Aldrighetti MD, PhD in Annals of Surgical Oncology (2020)

  16. No Access

    Article

    Colorectal Liver Metastasis in the Setting of Lymph Node Metastasis: Defining the Benefit of Surgical Resection

    For patients with colorectal liver metastasis (CLM), the presence of concomitant perihepatic/para-aortic lymph node metastasis (LNM) is considered a contraindication to liver resection. We sought to determine ...

    Carlo Pulitanò MD, Martin Bodingbauer MD in Annals of Surgical Oncology (2012)

  17. No Access

    Article

    Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis

    Hepatic resection for colorectal liver metastasis (CLM) with concomitant extrahepatic disease (EHD) is a controversial topic. We sought to evaluate the long-term outcome of patients undergoing liver resection ...

    Carlo Pulitanò MD, Martin Bodingbauer MD in Annals of Surgical Oncology (2011)

  18. No Access

    Article

    Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases

    Although hepatic artery infusion chemotherapy (HAIC) of floxuridine (FUDR) for colorectal liver metastases (CLM) can produce high response rates, data concerning preoperative HAIC are scarce. The aim of this s...

    Carlo Pulitanò MD, Marcella Arru MD, Marco Catena MD, PhD in Annals of Surgical Oncology (2008)